(page 6)
Dear N Davies,
Please find attached the response to your FOI internal review request.
Kind regards,
FOI Team
Safety & Surveillance Group...
Our reference: FOI 23/043
Dear Alex Hicks,
Thank you for your request under the Freedom of Information Act, we
apologise for the long dela...
Dear Natasha K
Thank you for your email.
In order to help assist with request we are grateful if you could provide us with your full name and also if...
Dear MHRA Customer Services,
I wrote to you on 26 April 2023 to request that you "reconsider your use of the s22 exemption in that it is unreasonable...
Dear D Turner,
Thank you for your reply. As stated in the Internal Review if you remain
dissatisfied, you may ask the Information Commissioner (...
FOI 23/326
Dear Malcolm Day,
Thank you for your email of 1st May where you have asked "please provide the following information for the Fluenz Tetra...
FOI 23/383
Dear Alice Sav,
Thank you for your email.
The MHRA does not intend to issue any additional standalone guidance on the revision of ICH gui...
FOI 23/210
Dear Alex Hicks
Thank you for your email.
Please find the Access guidance on vaccine strain changes linked on our
website...
FOI 23/162
Dear Mr B Kingsley,
Thank you for your email and we apologise for delay in response.
Please find attached the response to your FOI reques...
Dear Michelle vonAhn,
Thank you for your enquiry relating to Adcortyl in orabase, please see our
comments below:
Adcortyl in orabase for mouth...
Dear Tom,
Thank you for your enquiry to the MHRA.
There are no UK parallel import licences (PLPIs) that have been granted for Rybelsus according to o...
Internal Review of FOI 22/387
Dear Mr Jonathan Weissman
Thank you for your email.
Please find attached the reply to your Internal Rev...
FOI 23/211
Dear Mr Weissman,
Thank you for your information request dated 19 February 2022 where you
asked for information related COVID-1...
FOI 23/325
Dear Mr Weissman,
Thank you for your request under the Freedom of Information Act, we
apologise for the delay in response.
...
Mr Devlin
Apologies for the delay.
Reg 43 (5) of the 2012 Human Medicines Regulations provides a WDA holder mut not sell supply or offer a medicine un...
FOI 23/209
Dear Ankur Sangani,
Thank you for your email.
We do not receive these so we cannot provide the data and we advise that you contact the tr...
Dear Kayon,
Thank you for your information request, 12th April where you asked for - Can PCR TEST recognize if a virus is alive or dead
The Medicines...
FOI 21/199
Dear B Nicholls,
The authorisation of the Pfizer/BioNTech and the Oxford/AstraZeneca
vaccines was done through an expedited rolling...
FOI 21/417
Dear Barbara Slaska,
Thank you for your email.
Please find below answers to the questions you raise below;
1. Which go...
Dear Abdul Hai,
FOI 23/269
Thank you for your recent FOI request relating to the use of Artificial Intelligence (AI), specifically whether we have co...
FOI 23/014
Dear D Jackson,
Thank you for your email.
Please find attached the response and document to your FOI request.
Kind Regards
MHRA Custom...
Dear J Mwanzia,
Thank you for your request, we apologise for the delay in response.
Please find our response attached.
Kind regards...
Dear Tom,
Thank you for your enquiry to the MHRA.
I have attached a list of companies holding current UK parallel import licences (PLPIs) for Ozempic...
FOI 22/1075
Dear Julie Moffat,
Thank you for your email.
The temporary authorisations of the Pfizer/BioNTech, Oxford/AstraZeneca and Moderna vaccine...
FOI 23/091
Dear Jackson Bates,
Thank you for your emails below and attached. We apologise for delay in response.
Please find attached response.
Kin...
Dim ond ceisiadau a wnaed gan ddefnyddio WhatDoTheyKnow a ddangosir.
?